The plastic surgical emplacement of breast implant devices, either for breast reconstruction or for aesthetic purpose, presents the same health risks common to surgery, such as adverse reaction to anesthesia, hematoma (post-operative bleeding), late hematoma (post-operative bleeding after 6 months or more), seroma (fluid accumulation), incision-site breakdown (wound infection). Complications specific to breast augmentation include breast pain, altered sensation, impeded breast-feeding function, visible wrinkling, asymmetry, thinning of the breast tissue, and symmastia, the “bread loafing” of the bust that interrupts the natural plane between the breasts. Specific treatments for the complications of indwelling breast implants—capsular contracture and capsular rupture—are periodic MRI monitoring and physical examinations. Furthermore, complications and re-operations related to the implantation surgery, and to tissue expanders (implant place-holders during surgery) can cause unfavorable scarring in approximately 6–7 per cent of the patients.  Statistically, 20 per cent of women who underwent cosmetic implantation, and 50 per cent of women who underwent breast reconstruction implantation, required their explantation at the 10-year mark.
Breast reduction involves reducing the size of the breast. A breast lift involves lifting the nipple-areolar complex and reducing the excess skin of the breast. Breast reductions can involve just liposuction in patients who have more fatty tissue than glandular breast tissue. Liposuction alone indeed does reduce the volume of the breasts. However, sagging of the breast can result and liposuction alone is therefore performed usually in highly selected patients.
Many patients have concerns that after getting breast implants it may result in less accurate testing for breast cancer, but this is not something they need to worry about. This is a very valid concern but having implants will not make your mammograms less effective. As the rate of women with breast implants has increased, so has the knowledge of the radiologists and technicians, and they have become very adept at performing mammograms on women with implants. During the test and the test films produced, the implants will not obscure or hide any suspicious lesions or growths, but rather appear as a fain shadow. Any experienced radiologist will not have difficulty in viewing and/or diagnosing any suspicious lesions or detecting any breast cancer in a patient that has implants.
Fat transfer breast augmentation has a few important limitations. First, fat transfer is typically limited to approximately one cup size increase in breast size. Second, the transferred fat may be absorbed again by the body. Third, it is more expensive because of the extra time involved in harvesting and processing donor fat as well as possible need for a special vacuum bra device. This option is best reserved for women who desire a modest increase in size without using an implant.
In 1988, twenty-six years after the 1962 introduction of breast implants filled with silicone gel, the U.S. Food and Drug Administration (FDA) investigated breast implant failures and the subsequent complications, and re-classified breast implant devices as Class III medical devices, and required from manufacturers the documentary data substantiating the safety and efficacy of their breast implant devices. In 1992, the FDA placed silicone-gel breast implants in moratorium in the U.S., because there was “inadequate information to demonstrate that breast implants were safe and effective”. Nonetheless, medical access to silicone-gel breast implant devices continued for clinical studies of post-mastectomy breast reconstruction, the correction of congenital deformities, and the replacement of ruptured silicone-gel implants. The FDA required from the manufacturers the clinical trial data, and permitted their providing breast implants to the breast augmentation patients for the statistical studies required by the U.S. Food and Drug Administration. In mid–1992, the FDA approved an adjunct study protocol for silicone-gel filled implants for breast reconstruction patients, and for revision-surgery patients. Also in 1992, the Dow Corning Corporation, a silicone products and breast implant manufacturer, announced the discontinuation of five implant-grade silicones, but would continue producing 45 other, medical-grade, silicone materials—three years later, in 1995, the Dow Corning Corporation went bankrupt when it faced large class action lawsuits claiming a variety of illnesses.
The selection of a particular shape of implant is based on the look that the client is seeking to achieve. Feedback from patient tends to indicate that gel breast implants offer the most realistic feel. Silicone implants are filled prior to surgery, therefore require a slightly larger incision for insertion than saline. Smooth and textured shells of saline implants provide a beautiful shape to the breast.
The first point is placed at a distance of about one centimeter from the outer corner of the eye. Then the patient is asked to squint, if wrinkles appear above or below the first mark, additional points are applied. There is a danger of too close to the introduction of the drug, which can cause it to hang over, so the expert’s experience should not cause doubts. It is worthwhile in advance to look at the document confirming the qualification of the doctor.
There’s definitely no denying, the B word has definitely been a talking point of late, not just in the media, but within my close circle of friends too. Would you? Wouldn’t you? Have you? Has she? I promise it’s not as ‘Real Housewives of Cheshire’ as it sounds... But whilst I'm only 28, the reality is that the constant stream of late nights, binge drinking (sorry Mum) and falling asleep with a full face of makeup on, are all starting to show their effects.